期刊文献+

p21活化激酶4在胃癌中的表达及意义 被引量:1

Expression of PAK4 and its significance in gastric cancer
原文传递
导出
摘要 目的探讨p21活化激酶4(PAK4)在人胃癌组织和胃癌细胞系中的表达及与临床病理因素的关系。方法免疫组化法检测95例人胃癌组织中PAK4蛋白的表达;Westernblot法检测40例新鲜胃癌组织和相应的癌旁正常胃黏膜组织以及7种人胃癌细胞系中PAK4蛋白的表达。结果95例人胃癌组织中,PAK4蛋白的阳性表达率为67.4%(64/95),其中62例(96.9%)阳性染色位于细胞浆中,仅有2例(3.1%)位于细胞膜上。PAK4蛋白的阳性表达率与胃癌TNM分期(Χ^2=10.426,P〈0.01)和淋巴结转移(Χ^2=4.912,P〈0.05)有关。新鲜胃癌组织中PAK4蛋白的表达量显著高于癌旁正常胃黏膜组织(t=-5.978,P〈0.01),且随胃癌TNM分期的进展,其表达量逐渐增加。7种人胃癌细胞系中均有PAK4蛋白的表达,与GES-1细胞系相比,PAK4蛋自在ACTS、BGC823、MKN45和N87细胞系中呈高表达,而在MGC803、MKN1和SGC7901细胞系中呈低表达。结论PAK4蛋白的过度表达可能与人胃癌的发生发展及预后有关。 Objective To investigate the expression of p21-activated kinase4 (PAK4) in human gastric cancer, and to evaluate the correlation of PAK4 protein level with clinical pathologic parameters. Methods Immunohistochemical method was employed for detecting the expression of PAK4 in tissue samples obtained from 95 gastric cancer patients who underwent surgical treatment. Western blot was also used to measure the expression of PAK4 in gastric cancer tissues and adjacent non-cancerous gastric mucosa in 40 patients and also in 7 human gastric cancer cell lines. Results Immunohistochemical staining results showed that positive PAK4 expression in the gastric cancer tissues was 67.4%, and 96.9% of those (62/64) was located in the cytoplasm, while only 3.1% (2/64) was on the cell membrane. Expression of PAK4 was revealed to be significantly and positively correlated with both TNM stage (Χ^2 = 10. 426, P 〈 0.01 ) and lymph node metastasis (Χ^2 =4. 912, P 〈0.05 ). Western blot showed that PAK4 expression of gastric cancer tissues was significantly higher than that of adjacent non-cancerous gastric mucosa ( t = - 5. 978, P 〈 0.01 ). Expression of PAK4 could also be detected in 7 human gastric cancer cell lines. Compared with GES-1 , expression of PAK4 is higher in MKN45, AGS, N87 and BGC823, but it was lower in MGCS03, MKN1 and SGC7901. Conclusion The overexpression of p21-activated kinase4 (PAK4) may be correlated with the carcinogenesis and prognosis of gastric cancer.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2008年第1期30-33,共4页 Chinese Journal of Oncology
基金 国家自然科学基金资助项目(30370640、30370736)
关键词 胃肿瘤 p21活化激酶4 胃癌组织 Stomach neoplasms PAK4
  • 相关文献

参考文献10

  • 1潘阳林,毕锋,刘娜,杜静平,蒋海萍,薛妍,樊代明.Rac亚家族在胃肠道肿瘤细胞系中的表达及活性[J].中华肿瘤杂志,2003,25(5):441-444. 被引量:17
  • 2Callow MG, Clairvoyant F, Zhu S, et al. Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines. J Biol Chem, 2002, 277:550-558.
  • 3Gnesutta N, Qu J, Mindent A. The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J Biol Chrm, 2001, 276 : 14414-14419.
  • 4Li X, Minden A. PAK4 functions in TNF α induced survival pathways by facilitating TRADD binding to the TNF receptor. J Biol Chem, 2005, 280:41192-41200.
  • 5Dan C, Kelly A, Bernard O, et al. Cytoskeletal changes regulated by the PAK4 serine/threonine kinase are mediated by LIM kinase I and cofilin. J Biol Chem, 2001, 276:32115-32121.
  • 6Barac A, Basile J, Vazquez-Prado J, et al. Direct interaction of p21-activated kinase 4 with PDZ-RhoGEF, a G protein-linked Rho guanine exchange factor. J Biol chem, 2004, 279:6182-6189.
  • 7Callow MG, Zozulya S, Gishizky ML, et al. PAK4 mediates morphological changes through the regulation of GEF-H1. J Cell Sci, 2005, 118 : 1861-1872.
  • 8Zhang H, Li Z, Viklund EK, et al. p21-activated kinase 4 interacts with integrin αvβ5 and regulates αvβ5-mediated cell migration. J Cell Biol, 2002, 158 : 1287-1297.
  • 9Wells CM, Abo A, Ridley AJ. PAK4 is activated via PI3K in HGF-stimulated epithelial cells. J Cell Sci, 2002, 115:3947- 3956.
  • 10赵仲生,茹国庆,马杰.IGF-Ⅱ和HGF mRNA表达与胃癌微血管密度的关系[J].中华肿瘤杂志,2004,26(11):673-677. 被引量:27

二级参考文献11

  • 1Sahai E, Marshall CJ. Rho-GTPases and cancer. Nat Rev Cancer,2002, 2:133 - 142.
  • 2Ridley AJ. Bho GIPases and cell migration. J Cell Sci, 2001, 114:2713-2722.
  • 3Fritz G, Just I, Kaina B. Rho GTPases are over-expressed in human tumors. Int J Cancer, 1999, 81:682-687.
  • 4Fukata M, Watanabe T, Noritake J, et al. Racl and Cdc42 capture microtubules through IQGAP1 and CLIP-170. Cell, 2002, 109:873-885.
  • 5Hakeda-Sunaki S,Ng J, Tzu J, et al. Rac function and regulation during drosophila development . Nature. 2002. 416:438-442.
  • 6Pervaiz S, Cao J, Chao OS, et al. Activation of the RaeGTPase inhibits apoptosis in human tumor cells. Oncogene. 2001. 20:6263-6268.
  • 7Bi F, Debreceni B, Zhu K, et al. Autoinhibition mechanism of protoDbl. Mol Cell Biol, 2001. 21:1463-1474.
  • 8Schnelzer A, Prechtel D, Knaus U, et al. Racl in human breast cancer: overexpression, mutation analysis, and characterization of a new isdorm, Raclb. Oncogene, 2000, 19:3013-3020.
  • 9Abraham MT, Kuriakose MA, Sacks PC, et al. Motillty-related proteins as markers for head and neck squamous cell cancer, Laryngoscope,2001, 111:1285-1289.
  • 10Mira JP, Benard V, Groffen J, et al. Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-acfivated kinasedependent pathway. Proc Natl Acad Sci USA, 2000, 97:185-189.

共引文献42

同被引文献7

  • 1KUMAR R,GURURAJ A E,BARNES C J. p21-Activated kinases in cancer[ J]. Nat Rev Cancer,2006,6 (6) :459 -471.
  • 2ESWARAN J, SOUNDARARAJAN M, KNAPP S. Targeting group II PAKs in cancer and metastasis [ J ]. Cancer Metastasis Rev,2009,28 ( 1/2 ) :209 - 217.
  • 3LIU Y, XIAO H, TIAN Y, et al. The PAK4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice [J]. Mol Cancer Res, 2008,6 (7) :1215 - 1224.
  • 4PORCHIA L M, GUERRA M, WANG Y, et al. 2-Amino-N-{ 4-E 5-( 2-phenanthrenyl )-3-( trifluoromethyl )-1H-pyrazol-1-yl ]-phenyl} acetamide ( OSU- 03012), a celecoxib derivative, directly targets p21- activated kinase [J]. Mol Pharmacol, 2007,72 ( 5 ) : 1124 - 1131.
  • 5ESWARAN J, LEE W H, DEBRECZENI J E, et al. Crystal structures of the p21-activated kinases PAK4, PAK5, and PAK6 reveal catalytic domain plasticity of active group Ⅱ PAKs[J].Structure, 2007,15 ( 2 ) : 201 -213.
  • 6BOSTROM J, GREENWOOD J R, GOTTFRIES J. Assessing the performance of OMEGA with respect to retrieving bioactive conformations [ J ]. J Mol Graph Model,2003,21 ( 5 ) :449 - 462.
  • 7CHEESERIGHT T,MACKEY M,ROSE S,et al. Molecular field technology applied to virtual screening and finding the bioactive conformation [ J ]. Expert Opin Drug Discov ,2007,2 ( 1 ) :131 - 144.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部